novo glp-1 Novo, Lilly buoyed by fast-growing drug sales With FDA approval of Wegovy

That subtle shift is what separates GLP-1 weight loss from traditional approaches

14% with placebo, P = 0.46) [44]

GLP-1 receptor activation improves B cell function and survival following induction of endoplasmic reticulum stress

Speak to Analyst: Customize insights for your business strategy: Regional Outlook and Growth Opportunities The market demonstrates strong regional expansion trends: USA (17.1% CAGR): Leading commercialization and structured nutrition adoption UK (15.6% CAGR): Strong DTC nutrition ecosystem and meal replacement familiarity Germany (15.0% CAGR): Premium wellness and pharmacy-adjacent demand growth Japan (14.2% CAGR): Smaller-format convenience nutrition innovation South Korea (14.8% CAGR): Growth in functional wellness beverages and meal solutions North America remains the leading commercialization hub, while Europe and East Asia continue driving premiumization and innovation in portion-controlled nutrition formats

GLP-1RA drugs were associated with significant benefits to neurological and behavioral health, with reduced risks of seizures and addiction to substances such as alcohol, cannabis, stimulants and opioids

Ozempic acts as a GLP-1 receptor agonist that selectively binds to and activates the GLP-1 receptor, the target for native GLP-1